Education
About Us
Working with TipRanks
Follow Us
QuiaPEG Pharmaceuticals Holding AB (DE:99B0)
:99B0
99B0 Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€586.12K
Enterprise Value€6.95M
Total Cash (Recent Filing)€2.58M
Total Debt (Recent Filing)kr3.33M
Price to Earnings (P/E)―
Beta12.74
Next Earnings
Aug 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 30, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,124,285,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.06
Price to Sales (P/S)0.00
P/FCF Ratio-1.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
99B0 FAQ
What was QuiaPEG Pharmaceuticals Holding AB’s price range in the past 12 months?
Currently, no data Available
What is QuiaPEG Pharmaceuticals Holding AB’s market cap?
QuiaPEG Pharmaceuticals Holding AB’s market cap is €586.12K.
When is QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date?
QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date is Aug 28, 2025 which is in 38 days.
How were QuiaPEG Pharmaceuticals Holding AB’s earnings last quarter?
Currently, no data Available
Is QuiaPEG Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts QuiaPEG Pharmaceuticals Holding AB’s price is currently Overvalued.
Does QuiaPEG Pharmaceuticals Holding AB pay dividends?
QuiaPEG Pharmaceuticals Holding AB pays a Notavailable dividend of €0.506 which represents an annual dividend yield of N/A. See more information on QuiaPEG Pharmaceuticals Holding AB dividends here
What is QuiaPEG Pharmaceuticals Holding AB’s EPS estimate?
QuiaPEG Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuiaPEG Pharmaceuticals Holding AB have?
QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding.
What happened to QuiaPEG Pharmaceuticals Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of QuiaPEG Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in DE:99B0
Company Description
QuiaPEG Pharmaceuticals Holding AB
QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, develops biopharmaceutical products for the treatment of metabolic disorders. It develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. The company has strategic collaboration with Cobra Biologics AB for the refinement of biopharmaceutical products. The company was formerly known as Oligovation AB and changed its name to QuiaPEG Pharmaceuticals Holding AB (publ). QuiaPEG Pharmaceuticals Holding AB (publ) was founded in 2012 and is headquartered in Solna, Sweden.
Scandion Oncology A/S
―
Lipigon Pharmaceuticals AB
―
ExpreS2ion Biotech Holding AB
―
CombiGene AB
―
Fluicell AB
―